ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Liraglutide Ups Risk for Gallbladder, Biliary Tract Events
August 27, 2019There is an increased risk for gallbladder- or biliary tract-related events among patients with type 2 diabetes taking liraglutide versus placebo, according to a study published online in Diabetes Care. -
FDA Says Viberzi (eluxadoline) has an Increased Risk of Serious Pancreatitis in Patients without a G
March 17, 2017The U.S. Food and Drug Administration (FDA) is warning that Viberzi (eluxadoline), a medicine used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder.
Pharma Sources Insight January 2025
